Contineum Therapeutics
Clinical trials sponsored by Contineum Therapeutics, explained in plain language.
-
New MS pill shows promise in early trial
Disease control CompletedThis study tested an oral medication called PIPE-307 in 182 adults with relapsing-remitting multiple sclerosis (MS). Participants took either a low dose, a high dose, or a placebo pill for about 30 weeks. The main goals were to check for side effects and measure changes in vision…
Phase: PHASE2 • Sponsor: Contineum Therapeutics • Aim: Disease control
Last updated May 11, 2026 20:47 UTC
-
New pill aims to ease chronic joint and back pain
Symptom relief CompletedThis early-stage study tested whether an experimental oral drug called PIPE-791 is safe and can reduce pain in adults with long-term osteoarthritis knee pain or chronic low back pain. 43 participants stopped their usual pain medicines, then took either the study drug or a placebo…
Phase: PHASE1 • Sponsor: Contineum Therapeutics • Aim: Symptom relief
Last updated May 17, 2026 10:43 UTC